Insights

July 11, 2024

Private Health Management Advocates for Better Use of Clinical Trials

Private Health Management ("PHM"), a clinically sophisticated complex care management firm, announces the release of its whitepaper, "The Importance of Clinical Trials in Cancer Care." This report highlights the critical role of clinical trials in advancing cancer treatment, improving patient outcomes, and lowering costs for employers. Read now

July 11, 2024

The Importance of Clinical Trials in Cancer Care

Clinical trials are pivotal in advancing cancer treatment and improving patient outcomes. They offer patients access to cutting-edge treatments while contributing valuable insights that drive the evolution of cancer care. This whitepaper examines clinical trials as a potential value lever within employer-sponsored health plans, highlighting their dual impact on enhancing cancer care and managing healthcare costs. Read now

June 12, 2024

Navigating a diagnosis with a rare form of Alzheimer’s

Facing a diagnosis of Alzheimer's disease at a young age can be shocking and frightening for patients and their families. James*, an active 50-year-old executive, began experiencing memory lapses, such as forgetting co-workers’ names and simple addresses. Seeking further assistance, James turned to PHM upon a family member's recommendation. Read now

June 12, 2024

Protecting yourself from tick-borne illnesses

During the warm months of spring and summer, the looming threat of ticks becomes more palpable. While most people are aware of Lyme disease as the primary concern, ticks carry a staggering array of 13 other diseases. Read now

June 12, 2024

Exploring a rare form of Alzheimer’s disease affecting younger individuals

Alzheimer’s disease, the most common form of dementia in the United States, affects millions of Americans, predominately striking after the age of 60. However, there is a lesser-known rare variant of Alzheimer’s called Posterior Cortical Atrophy (PCA) that makes up about 5% of cases. Read now

June 12, 2024

FDA approves the first treatment to reduce the severity of food allergy reactions

For the first time, the FDA has approved a treatment to reduce the severity of dangerous allergic reactions due to accidental exposure to food allergens. Here’s what to know about this new tool to help manage food allergies. Read now

May 22, 2024

Living and thriving as a cancer survivor

Becky, a vibrant and active woman, faced a life-altering diagnosis of Stage IV lung cancer. Guided by PHM's Personal Care Team and the power of molecular profiling, Becky's treatment evolved based on her unique genetic markers, leading to remarkable progress. Read now

April 30, 2024

COVID-19 and its impact on high-risk groups

There have been a few COVID-19 updates in the news in the last month. It is important for people who are at high-risk of serious illness to be aware of these changes, including adults aged 65 years and older, pregnant people, children aged 5 years and under, and people with weakened immune systems due to medical conditions or immunosuppressive treatments. Read now

April 17, 2024

Optimizing Cancer Care and Costs

Natalya Gertsik, PhD, Vice President of ClearCancer Solution, and Tommy Axford, FSA, MAAA, SVP Strategic Partnerships, join Springbuk’s “Healthcare Rocks” podcast to discuss PHM’s cutting-edge solution, ClearCancer, and how employers and advisors are adopting data-driven strategies to address the challenges of high-cost cancer treatments. Listen now

April 15, 2024

How to talk to kids about cancer

At PHM, we advocate for a family-centered approach to care. Alongside our highly skilled advanced practice clinicians, PhD-led research scientists, and expert coordinators, we offer the support of Certified Child Life Specialists in-house. These specialists assist our clients in having difficult conversations with their children following a new cancer diagnosis and prepare them for what emotional or behavioral reactions they can expect. Read now

March 07, 2024

Gene editing-based therapies could revolutionize how genetic diseases are treated

Patients with the debilitating, inherited blood disorders sickle cell anemia and beta-thalassemia recently received news of a life-changing treatment. The FDA approved Casgevy, a groundbreaking therapy that uses a gene editing tool called CRISPR (pronounced ‘crisper’) to treat these disorders. This is the first ever approval for this innovative type of treatment, which can change the DNA code in a patient’s cells to target the underlying cause of a disease. Read now